Difficult discussions now can ease difficult decisions later for patients with heart failure

Patients with advanced heart failure should have ongoing conversations with their healthcare providers to make informed decisions about treatment options that match their personal values, goals and preferences, according to a scientific statement published in the American Heart Association journal, Circulation.

Shared decision making extends beyond , requiring that and patients consider information together and work toward consensus. This process should focus on the outcomes that are most important to the patients, including not only survival but also relief of symptoms, quality of life and living at home.

Decision making for advanced heart failure is becoming particularly important but also increasingly challenging as patients are living longer with their and treatment options continue to expand, including complex new technologies.

"For patients with advanced heart failure, the decision-making process should be proactive, anticipatory, and patient-centered. This involves talking about goals of care, expectations for the future, and the full range treatment options, including ," said lead author Larry A. Allen, M.D., M.H.S., assistant professor of medicine at the University of Colorado Anschutz Medical Center.

As the time required for shared decision making is difficult to fit into a regular clinic visit in the middle of a busy clinical practice, the authors propose an annual review to discuss prognosis, consider reasonable therapies, and clarify the patient's values, goals and preferences. This review is in addition to, not a replacement for, additional discussions triggered by events such as hospitalizations and other changes in the patient's health. "The process of checking in with patients on a regular basis is extremely important because heart failure and change over time," said Dr. Allen.

In the United States, nearly three percent of adults have heart failure, with higher rates among older patients. Heart failure occurs when the heart becomes too weak to pump enough blood to meet the body's needs, causing shortness of breath, ankle swelling, and fatigue. Many diseases can weaken the heart, including blocked blood vessels, high blood pressure, and other conditions.

Heart failure tends to progress over time. Early heart failure can often be managed with oral medicines and lifestyle changes in diet, stopping smoking and exercise; however, advanced requires consideration of additional treatments, including pacemaker devices and surgically implanted mechanical pumps to increase blood flow to the body. In a small number of cases, heart transplantation may be an option. Central to the is understanding that "doing everything" is not always the right thing. For many patients with advanced disease, receiving symptom relief, comfort, and support along with medical therapy are preferred.

The authors caution that shared decision making will be limited until the healthcare system shifts its emphasis from reimbursement for specific therapies to better reimbursement for meaningful conversations about which therapies should and should not be pursued for each individual patient.

add to favorites email to friend print save as pdf

Related Stories

Heart failure patients have new hope

Feb 13, 2012

"Despite the increasing number of people affected, the prognosis for patients with heart failure has steadily improved," said Gregg C. Fonarow, M.D, chairman of American Heart Association Hospital Accreditation Science Committee ...

New heart failure device is tested

Oct 17, 2006

Physicians at 50 U.S. medical facilities are taking part in a multinational clinical trial of a device designed to help heart failure victims.

Recommended for you

A global view on the prevention of cardiovascular disease

18 hours ago

The United Nations and the World Health Organization pledged in 2011 to reduce premature mortality from non-communicable diseases - most notably cardiovascular diseases - by 25% by the year 2025. It's an ambitious target, ...

Stroke healthcare inequalities remain in the UK

Apr 15, 2014

The quality of healthcare provided after a stroke remains uneven in the UK, according to a new study led by King's College London. Despite improvements in equal access to healthcare since 2001, patients from ...

FDA approves expanded indication for CRT devices

Apr 15, 2014

(HealthDay)—The U.S. Food and Drug Administration has approved an application from Medtronic for revised labeling for two cardiac resynchronization pacemakers (CRT-P) and eight cardiac resynchronization ...

User comments